Aliqopa™ (copanlisib) – New orphan drug approval
September 14, 2017 – The FDA announced the approval of Bayer’s Aliqopa (copanlisib) for the treatment of adult patients with relapsed follicular lymphoma (FL) who have received at least two prior systemic therapies.
Download PDF
